Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UAS Pharmaceuticals is an Australian-based pharmaceutical company specializing in the research, development, and manufacturing of dermatological and personal care products. The company focuses on providing therapeutic solutions for various skin conditions, including acne, hyperpigmentation, and inflammatory disorders like eczema and psoriasis. Their product portfolio features well-known brands such as Neutriderm and Dermavive, which utilize natural ingredients like colloidal oatmeal and specialized antioxidants. UAS Pharmaceuticals operates globally, distributing its products across the Middle East, Asia, and the Americas. The company maintains its own manufacturing facilities to ensure high-quality standards for its topical formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UAS Pharmaceuticals.